question: Is there an association between TERT promoter mutation and survival of glioblastoma patients?
answer: Telomerase reverse transcriptase (TERT) promoter are associated with shorter survival of glioblastoma patients. Prognostic value of TERT mutations for poor survival is largely due to their inverse correlation with IDH1 mutations.